Home » Clinical Trials » Diabetic Retinopathy
Clinical Trial Details
Research Study Summary
A clinical research study for the treatment of Diabetes or Retinal Disorders
Research Study Title
Developing a Non-invasive Method and Device for Assessing the Degree of Midperipheral Retinal Ischemia in Diabetic Retinopathy.
The basic objective of this project is to test a modification of existing technology for
monitoring the responses of the pupil to light as a method for detecting regional losses of
function of the retina. The "instrument" consists of a commercially available set of goggles
that monitor the eye positions and pupils using infrared light and small cameras. The
signals from the monitoring cameras are collected in a computer that records how their
pupils have responded to each lighting condition. Because diabetics develop damage initially
to certain parts of the retina before they have more serious damage, the ultimate goal of
this research is to develop a simple, noninvasive, rapid method for widespread screening of
diabetics in order to identify those who may require medical attention and/or therapy for
To Learn more
Both Male and Female
Both Male and Female ages 18 Years and up
All subjects: must be greater than 18 years of age and capable of understanding
All subjects must be willing to tolerate the placement of a set of goggles on their
All subjects must have visual acuities of 20/60 or better in at least one eye.
Normal subjects must have a history of a normal eye examination within one year prior
to participation in this study.
Normal subjects must have no history of ocular disease and no history of diabetes.
Diabetic subjects must be diagnosed with diabetes upon prior clinical examination.
Retinal Conditions subjects must be diagnosed with a retinal pathology, hereditary or
Site Locations (2)
||Jules Stein Eye Institute, Dept. of Ophthalmology, David Geffen School of Medicine at UCLA
Michael B. Gorin, MD, PhD
Michael B. Gorin, MD, PhD
Maria Carolina Ortube, MD
Steve Nusinowitz, PhD
||Neuro Kinetics Inc.
Alexander Kiderman, PhD
NCT ID: NCT01546766
Date Last Changed: April 4, 2013
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials. Some study summaries have been edited for clarity purposes to make them easier to understand. View more study details here.